Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma

Sci Rep. 2017 Apr 21:7:46645. doi: 10.1038/srep46645.
No abstract available

Publication types

  • Published Erratum